Edwards Lifesciences (EW +2.7%) news roundup: Company authorizes a new $750M buyback program and says it will complete the remainder ($140M) of its previously authorized repurchase program during Q2; CEO Michael Mussallem will purchase $5M worth of shares tomorrow at either Wednesday's closing price or the average closing price for the 10 trading days ending Monday, whichever is higher; CFO Thomas Abate will retire this year. Despite a 5-day, ~5% rally, the shares are still reeling from April 24th's post-earnings dive and subsequent downgrades.
Edwards Lifesciences (EW +2.7%) news roundup: Company authorizes a new $750M buyback program and...
Recommended For You
More Trending News
About EW Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
EW | - | - |
Edwards Lifesciences Corporation |